Phase 3
Completed N=1,008
Individualizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention - The IDEAL-PCI Registry
Platelet Inhibition · Coronary Stent Implantation
Source: ClinicalTrials.gov NCT01515345 ↗
Enrolled (actual)
1,008
Serious AEs
4.4%
Results posted
May 2013
Primary outcomePrimary: Definite Stent Thrombosis — 1; 0 participants
Summary
The purpose of this study is to determine the efficacy and safety of a routine individualized antiplatelet therapy after coronary stent implantation by evaluating "on-treatment" platelet reactivity with Multiple Electrode Aggregometry (MEA, Multiplate® Analyzer).
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Definite Stent Thrombosis |
1; 0 | — |
| PRIMARY Any Bleeding Event |
17; 9 | — |
| SECONDARY Probable Stent Thrombosis |
2; 0 | — |
Eligibility Criteria
Inclusion Criteria
- all consecutive PCI patients with stent implantation of our institution
Exclusion Criteria
- pregnancy
Data sourced from ClinicalTrials.gov (NCT01515345). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.